<?xml version="1.0" encoding="UTF-8"?>
<p id="d1e1964">In late December 2019, highly contagious pneumonia of unknown etiology was first reported in Wuhan, China 
 <xref rid="b1" ref-type="bibr">[1]</xref>, 
 <xref rid="b2" ref-type="bibr">[2]</xref>, 
 <xref rid="b3" ref-type="bibr">[3]</xref>, 
 <xref rid="b4" ref-type="bibr">[4]</xref>, 
 <xref rid="b5" ref-type="bibr">[5]</xref>, 
 <xref rid="b6" ref-type="bibr">[6]</xref>, 
 <xref rid="b7" ref-type="bibr">[7]</xref>, 
 <xref rid="b8" ref-type="bibr">[8]</xref>, 
 <xref rid="b9" ref-type="bibr">[9]</xref>. A novel strain of coronavirus was isolated from patients and named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the World Health Organization 
 <xref rid="b10" ref-type="bibr">[10]</xref>. Since then, SARS-CoV-2 infection has been detected in about 190 countries and caused more than 600,000 deaths worldwide 
 <xref rid="b9" ref-type="bibr">[9]</xref>, 
 <xref rid="b11" ref-type="bibr">[11]</xref>, 
 <xref rid="b12" ref-type="bibr">[12]</xref>, 
 <xref rid="b13" ref-type="bibr">[13]</xref>, 
 <xref rid="b14" ref-type="bibr">[14]</xref>, 
 <xref rid="b15" ref-type="bibr">[15]</xref>. Infected individuals develop acute respiratory distress syndrome (ARDS) characterized by lymphocytopenia and hyperactive inflammatory response, which becomes the major cause of lung damage and consequent death 
 <xref rid="b16" ref-type="bibr">[16]</xref>. High-throughput sequencing demonstrates that SARS-CoV-2 highly resembles the severe acute respiratory syndrome (SARS-CoV) and the Middle East respiratory syndrome (MERS-CoV), both classified as 
 <italic>beta coronaviruses</italic> identified in bats 
 <xref rid="b17" ref-type="bibr">[17]</xref>, 
 <xref rid="b18" ref-type="bibr">[18]</xref>, 
 <xref rid="b19" ref-type="bibr">[19]</xref>, 
 <xref rid="b20" ref-type="bibr">[20]</xref>, 
 <xref rid="b21" ref-type="bibr">[21]</xref>. Its genome sequence is 96.2% identical to the bat CoV RaTG13 
 <xref rid="b22" ref-type="bibr">[22]</xref>. It uses the angiotensin-converting enzyme 2 (ACE2), the same receptor used by SARS-CoV 
 <xref rid="b23" ref-type="bibr">[23]</xref>, 
 <xref rid="b24" ref-type="bibr">[24]</xref>, 
 <xref rid="b25" ref-type="bibr">[25]</xref>, 
 <xref rid="b26" ref-type="bibr">[26]</xref>, 
 <xref rid="b27" ref-type="bibr">[27]</xref>, to infect humans.
</p>
